Neurological complications of celiac disease;Complicaciones neurológicas de la enfermedad celíaca

Medicina Clinica

Volumn 127, Issue 13, 2006, Pages 500-507

  Bermejo Velasco, Pedro Emilio ^a   Burgos García, Aurora ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIMIGRAINE AGENT; AZATHIOPRINE; CYCLOSPORIN; GLUTEN; INFLIXIMAB; NEUROLEPTIC AGENT; VITAMIN;

ATAXIA; AUTISM; CELIAC DISEASE; CLINICAL FEATURE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; EPILEPSY; HEADACHE; HISTOPATHOLOGY; HUMAN; LEARNING DISORDER; MENTAL DISEASE; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; PATHOGENESIS; PERIPHERAL NEUROPATHY; REVIEW; SURGICAL TECHNIQUE; VITAMIN SUPPLEMENTATION;

EID: 33750973356     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13093268     Document Type: Article

References (161)

1. Luostarinen L, Pirttila T, Collin P. Coeliac disease presenting with neurological disorders. Eur Neurol. 1999;42:132-5.
2. Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics. 2004;11:1672-6.
3. Casellas Jordà F. Enfermedad cellaca. Med Clin (Barc). 2006;126:137-42.
4. Campo C, Alonso R, Montera M, Todolí J, Bosch N, Calabuig JR. Enfermedad celíaca del adulto: estudio de 21 casos y revisión de la bibliografía. Gastroenterol Hepatol. 2001;24:236-9.
5. Harding AE, Muller DP, Thomas PK, Willison HJ. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann Neurol. 1982;12:419-24.
6. Chinnery PF, Reading PJ, Milne D, Gardner-Medwin D, Turnbull DM. CSF antigliadin antibodies and the Ramsay Hunt syndrome. Neurology. 1997;49:1131-3.
7. Schrodl D, Kahlenberg F, Peter-Zimmer K, Hermann W, Kuhn HJ, Mothes T. Intrathecal synthesis of autoantibodies against tissue transglutaminase. J Autoimmun. 2004;22:335-40.
8. Marsh MN. The natural history of gluten sensitivity: defining, refining and re-defining. QJM. 1995;88:9-13.
9. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol. 2005;3:843-51.
10. Kinney HC, Burger PC, Hurwitz BJ, Hijmans JC, Grant JP. Degeneration of the central nervous system associated with celiac disease. J Neural Sci. 1982;53:9-22.
11. Brucke T, Kollegger H, Schmidbauer M, Muller C, Podreka I, Deecke L. Adult coeliac disease and brainstem encephalitis. J Neurol Neurosurg Psychiatry. 1988;51:456-7.
12. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain. 1966;89:683-722.
13. Finelli PF, McEntee WJ, Ambler M, Kestenbaum D. Adult celiac disease presenting as cerebellar syndrome. Neurology. 1980;30:245-9.
14. Wills AJ, Turner B, Lock RJ, Johnston SL, Unsworth DJ, Fry L. Dermatitis herpetiformis and neurological dysfunction. J Neurol Neurosurg Psychiatry. 2002;72:259-61.
15. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet. 1996;347:369-71.
16. Lahat E, Broide E, Leshem M, Evans S, Scapa E. Prevalence of celiac antibodies in children with neurologic disorders. Pediatr Neurol. 2000;22:393-6.
17. Kieslich M, Errazuriz G, Posselt HG, Moeller-Hartmann W, Zanella F, Boehles H. Brain white-matter lesions in celiac disease: a prospective study of 75 diet-treated patients. Pediatrics. 2001;108:E21.
18. Chapman RW, Laidlow JM, Colin-Jones D, Eade OE, Smith CL. Increased prevalence of epilepsy in coeliac disease. Br Med J. 1978;2:250-1.
19. Pratesi R, Gandolfi L, Martins RC, Tauil PL, Nobrega YK, Teixeira WA. Is the prevalence of celiac disease increased among epileptic patients? Arq Neuropsiquiatr. 2003;61:330-4.
20. Luostarinen L, Dastidar P, Collin P, Peraaho M, Maki M, Erila T, et al. Association between coeliac disease, epilepsy and brain atrophy. Eur Neurol. 2001;46:187-91.
21. Cronin CC, Jackson LM, Feighery C, Shanahan F, Abuzakouk M, Ryder DQ, et al. Coeliac disease and epilepsy. QJM. 1998;91:303-8.
22. Baquero M, Narciso ML, García M, Perla C, Domínguez F. Celiaquía con calcificaciones occipitales: dos casos tardíos. Med Clin (Barc). 1995;105:781-3.
23. Visakorpi JK, Kuitunen P, Pelkonen P. Intestinal malabsorption: a clinical study of 22 children over 2 years of age. Acta Paediatr Scand. 1970;59:273-80.
24. Martínez-Bermejo A, Polanco I, Royo A, López-Martín V, Areas J, Tendero A, et al. Estudio del síndrome de Gobbi en la población española. Rev Neurol. 1999;29:105-10.
25. Hernández MA, Colina G, Ortigosa L. Epilepsy, cerebral calcifications and clinical or subclinical coeliac disease. Course and follow up with gluten-free diet. Seizure. 1998;7:49-54.
26. Fois A, Vascotto M, Di Bartolo RM, Di Marco V. Celiac disease and epilepsy in pediatric patients. Childs Nerv Syst. 1994;10:450-4.
27. Gobbi G. Coeliac disease, epilepsy and cerebral calcifications. Brain Dev. 2005;27:189-200.
28. Yong LW, Jequier S, O'Gorman AM. Intracerebral calcifications in treated leukemia in a child. Am J Dis Child. 1977;131:1283-5.
29. Borns PF, Rancier LF. Cerebral calcifications in childhood leukemia mimicking Sturge-Weber syndrome. AJR Am J Roentgenol. 1974;122:52-5.
30. Lanzkowsky P. Congenital malabsorption of folate. Am J Med. 1970;48:580-3.
31. Gobbi G, Bouquet F, Greco L, Lambertini A, Tassinari CA, Ventura A, et al. Coeliac disease, epilepsy, and cerebral calcifications. Lancet. 1992;340:439-43.
32. Pratesi R, Modelli IC, Martins RC, Almeida PL, Gandolfi L. Celiac disease and epilepsy: favorable outcome in a child with difficult to control seizures. Acta Neurol Scand. 2003;108:290-3.
33. Cernibori A, Gobbi G. Partial seizures, cerebral calcifications and celiac disease. Ital J Neurol Sci. 1995;16:187-91.
34. Mavroudi A, Karatza E, Papastavrou T, Panteliadis C, Spiroglou K. Successful treatment of epilepsy and celiac disease with a gluten-free diet. Pediatr Neurol. 2005;33:292-5.
35. Díaz RM, González-Rabelino G, Delfino A. Epilepsia, calcificaciones cerebrales y enfermedad celíaca. Importancia del diagnóstico precoz. Rev Neurol. 2005;40:417-20.
36. Volta U, Bellentani S, Bianchi FB, Brandi G, De Franceschi L, Miglioli L, et al. High prevalence of celiac disease in Italian general population. Dig Dis Sci. 2001;46:1500-5.
37. De Freitas IN, Sipahi AM, Damiao AO, De Brito T, Cancado EL, Leser PG, et al. Celiac disease in Brazilian adults. J Clin Gastroenterol. 2002;34:430-4.
38. Pfaender M, D'Souza WJ, Trost N, Litewka L, Paine M, Cook M. Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and coeliac disease: a case series. J Neurol Neurosurg Psychiatry. 2004;75:1623-5.
39. Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry. 1999;66:32-5.
40. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998;352:1582-5.
41. Hadjivassiliou M, Grunewald R, Sharrack B, Sanders D, Lobo A, Williamson C, et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain. 2003;126:685-91.
42. Ward ME, Murphy JT, Greenberg GR. Celiac disease and spinocerebellar degeneration with normal vitamin E status. Neurology. 1985;35:1199-201.
43. Battisti C, Dotti MT, Formichi P, Bonuccelli U, Malandrini A, Carrai M, et al. Disappearance of skin lipofuscin storage and marked clinical improvement in adult onset coeliac disease and severe vitamin E deficiency after chronic vitamin E megatherapy. J Submicrosc Cytol Pathol. 1996;28:339-44.
44. Hadjivassiliou M, Boscolo S, Davies-Jones GA, Grunewald RA, Not T, Sanders DS, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology. 2002;58:1221-6.
45. Krupickova S, Tuckova L, Flegelova Z, Michalak M, Walters JR, Whelan A, et al. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease. Gut. 1999;44:168-73.
46. Kumar R, Lumsden A, Ciclitira PJ, Ellis HJ, Laurie GW. Human genome search in celiac disease using gliadin cDNA as probe. J Mol Biol. 2000;300:1155-67.
47. Abele M, Schols L, Schwartz S. Klockgether T. Prevalence of antigliadin antibodies in ataxia patients. Neurology. 2003;60:1674-5.
48. Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol. 2001;49:540-3.
49. Shill HA, Alaedini A, Bushara KO, Latov N, Hallett M. Anti-ganglioside antibodies in idiopathic and hereditary cerebellar degeneration. Neurology. 2003;60:1672-3.
50. Hadjivassiliou M, Davies-Jones GA, Sanders DS, Grunewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003;74:1221-4.
51. Rosenberg NR, Vermeulen M. Snould coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J Neurol Neurosurg Psychiatry. 2005;76:1415-9.
52. Cicarelli G, Della Rocca G, Amboni M, Ciacci C, Mazzacca G, Filla A, et al. Clinical and neurological abnormalities in adult celiac disease. Neurol Sci. 2003;24:311-7.
53. Chin RL, Sander HW. Brannagan TH, Green PH, Hays AP, Alaedini A, et al. Celiac neuropathy. Neurology. 2003;60:1581-5.
54. Kaplan JG, Pack D, Horoupian D, DeSouza T, Brin M, Schaumburg H. Distal axonopathy associated with chronic gluten enteropathy: a treatable disorder. Neurology. 1988;38:642-5.
55. Kelkar P, Ross MA, Murray J. Mononeuropathy multiplex associated with celiac sprue. Muscle Nerve. 1996;19:234-6.
56. Banerji NK, Hurwitz LJ. Neurological manifestations in adult steatorrhoea (probable gluten enteropathy). J Neurol Sci. 1971;14:125-41.
57. Usai P, Usai Satta P, Lai M, Corda MG, Piras E, Calcara C, et al. Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest. 1997;27:1009-15.
58. Usai P, Usai Satta P, Savarino V, Boy MF. Autonomic neuropathy in adult celiac disease. Am J Gastroenterol. 1996;91:1676-7.
59. Alaedini A, Wirguin I, Latov N. Ganglioside agglutination immunoassay for rapid detection of autoantibodies in immune-mediated neuropathy. J Clin Lab Anal. 2001;15:96-9.
60. Alaedini A, Green PH, Sander HW, Hays AP, Gamboa ET, Fasano A, et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol. 2002;127:145-8.
61. Simonati A, Battistella PA, Guariso G, Clementi M, Rizzuto N. Coeliac disease associated with peripheral neuropathy in a child: a case report. Neuropediatrics. 1998;29:155-8.
62. Polizzi A, Finocchiaro M, Parano E, Pavone P, Musumeci S, Polizzi A. Recurrent peripheral neuropathy in a girl with celiac disease. J Neurol Neurosurg Psychiatry. 2000;68:104-5.
63. Martínez-Bermejo A, Polanco I, Arcas J, López-Martín V, Roche C. Tendero A, et al. Prevalencia de la cefalea en una población de enfermos celíacos. Rev Neurol. 2001;32:301-9.
64. Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, et al. Association between migraine and celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003;98:625-9.
65. Zarkadas M, Cranney A, Case S, Molloy M, Switzer C, Graham ID, et al. The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet. 2006;19:41-9.
66. Rashid M, Cranney A. Zarkadas M, Graham ID, Switzer C, Case S, et al. Celiac disease; evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics. 2005;116:e754-9.
67. Serratrice J, Disdier P, De Roux C, Christides C, Weiller PJ. Migraine and coeliac disease. Headache. 1998;38:627-8.
68. Crosato F, Senter S. Cerebral occipital calcifications in celiac disease. Neuropediatrics. 1992;23:214-7.
69. Battistella PA, Mattesi P, Casara GL, Carollo C, Condini A, Allegri F, et al. Bilateral cerebral occipital calcifications and migraine-like headache. Cephalalgia. 1987;7:125-9.
70. D'Amico D, Rigamonti A, Spina L, Bianchi-Marzoli S, Vecchi M, Bussone G. Migraine, celiac disease, and cerebral calcifications: a new case. Headache. 2005;45:1263-7.
71. Cinquetti M, Trabucchi C, Menegazzi N, Comucci A, Bressan F, Zoppi G. Psychological problems connected to the dietary restrictions in the adolescent with coeliac disease. Pediatr Med Chir. 1999;21:279-83.
72. Martínez-Bermejo A, Polanco I. Alteraciones neuropsicoló gicas en la enfermedad celíaca. Rev Neurol. 2002;34 Supl 1:24-33.
73. Daynes G. Bread and tears; naughtiness, depression and fits due to wheat sensitivity. Proc R Soc Med. 1956;49:391-4.
74. Ciacci C, Cavallaro R, Romano R, Galletta DS, Labanca F, Marino M, et al. Increased risk of surgery in undiagnosed celiac disease. Dig Dis Sci. 2001;46:2206-8.
75. Ricca V, Mannucci E, Calabro A, Bernardo MD, Cabras PL, Rotella CM. Anorexia nervosa and celiac disease: two case reports. Int J Eat Disord. 2000;27:119-22.
76. Jost PJ, Stengel SM, Huber W, Sarbia M, Peschel C, Duyster J. Very severe iron-deficiency anemia in a patient with celiac disease and bulimia nervosa: a case report. Int J Hematol. 2005;82:310-1.
77. Carta MG, Hardoy MC, Usai P, Carpiniello B, Angst J. Recurrent brief depression in celiac disease. J Psychosom Res. 2003;55:573-4.
78. Ciacci C, Iavarone A, Siniscalchi M, Romano R, De Rosa A. Psychological dimensions of celiac disease: toward an integrated approach. Dig Dis Sci. 2002;47:2082-7.
79. Ciacci C, De Rosa A, De Michele G, Savino G, Squillante A, Iovino P, et al. Sexual behaviour in untreated and treated coeliac patients. Eur J Gastroenterol Hepatol. 1998;10:649-51.
80. Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality «trait» or a reactive illness? Hepatogastroenterology. 1996;43:1513-7.
81. Carta MG, Hardoy MC, Boi MF, Mariotti S, Carpiniello B, Usai P. Association between panic disorder, major depressive disorder and celiac disease: a possible role of thyroid autoimmunity. J Psychosom Res. 2002, 53:789-93.
82. Hallert C, Allenmark S, Larsson-Cohn U, Sedvall G. High level of pyndoxal 5′-phosphate in the cerebrospinal fluid of adult celiac patients Am J Clin Nutr. 1982;36:851-4.
83. Pynnonen PA, Isometsa ET, Verkasalo MA, Kahkonen SA, Sipila I, Savilahti E, et al. Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study. BMC Psychiatry. 2005;5:14.
84. Corvaglia L, Catamo R, Pepe G, Lazzari R, Corvaglia E. Depression in adult untreated celiac subjects: diagnosis by the pediatrician. Am J Gastroenterol. 1999;94:839-43.
85. Addolorato G, Capristo E, Ghittoni G, Valeri C, Masciana R, Ancona C, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scand J Gastroenterol. 2001;36:502-6.
86. Ciacci C, Iavarone A, Mazzacca G, De Rosa A. Depressive symptoms in adult coeliac disease. Scand J Gastroenterol. 1998;33:247-50.
87. Bender L, Childhood schizophrenia. Psychiatr Q. 1953;27:663-81.
88. Dohan FC. Is celiac disease a clue to the pathogenesis of schizophrenia? Ment Hyg. 1969;53:525-9.
89. Dohan FC. Coeliac disease and schizophrenia. Lancet. 1970;1:897-8
90. Dohan FC. Celiac disease and schizophrenia. N Engl J Med. 1980;302:1262.
91. Dohan FC. Schizophrenia, celiac disease, gluten antibodies, and the importance of beta. Biol Psychiatry. 1981;16:1115-7.
92. Walsh D. Coeliac disease and schizophrenia. Br Med J. 1973;2:242.
93. McGuffin P, Gardiner P, Swinburne LM. Schizophrenia, celiac disease, and antibodies to food. Biol Psychiatry. 1981;16:281-5.
94. Kalaydjian AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand. 2006;113:82-90.
95. West J, Logan RF, Hubbard RB, Card TR. Risk of schizophrenia in people with coeliac disease, ulcerative colitis and Crohn's disease: a general population-based study. Aliment Pharmacol Ther. 2006;23:71-4
96. Dohan FC, Grasberger JC. Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Am J Psychiatry. 1973;130:685-8.
97. De Santis A, Addolorato G, Romito A, Caputo S, Giordano A, Gambassi G, et al. Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J Intern Med. 1997;242:421-3.
98. Maestrini E, Paul A, Monaco AP, Bailey A. Identifying autism susceptibility genes. Neuron. 2000;28:19-24.
99. Bailey DB Jr, Hatton DD, Skinner M, Mesibov G. Autistic behavior. FMR1 protein, and developmental trajectories in young males with fragile X syndrome. J Autism Dev Disord. 2001;31:165-74.
100. Sahley TL, Panksepp J. Brain opioids and autism: an updated analysis of possible linkages. J Autism Dev Disord. 1987;17:201-16.
101. Wakefield AJ, Ashwood P, Limb K, Anthony A. The significance of ileocolonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol. 2005;17:827-36.
102. Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. 2003;23:504-17.
103. Shattock P, Whiteley P. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets, 2002;6:175-83.
104. Knivsber AM, Reichelt KL, Nodland M. Reports on dietary intervention in autistic disorders. Nutr Neurosci. 2001;4:25-37.
105. Gordon N. Vitamin E deficiency and illness in childhood. Dev Med Child Neurol. 1987;29:546-9.
106. 12 deficiency in untreated celiac disease. Am J Gastroenterol. 2001;96:745-50.
107. Lerner A, Gruener N, lancu TC. Serum carnitine concentrations in coeliac disease. Gut. 1993;34:933-5.
108. Carnevale V, Filabozzi P, Cela P, Scillitani A. Tiredness: a feature of coeliac disease. Age Ageing. 2000;29:462-3.
109. Siniscalchi M, Iovino P, Tortora R, Forestiero S, Somma A, Capuano L, et al. Fatigue in adult coeliac disease. Aliment Pharmacol Ther. 2005;22:489-94.
110. Pereira AC, Edwards MJ, Buttery PC, Hawkes CH, Quinn NP, Giovannoni G, et al. Choreic syndrome and coeliac disease: a hitherto unrecognised association. Mov Disord. 2004;19:478-82.
111. Wittstock M, Grossmann A, Kunesch E, Benecke R. Symptomatic vascular dystonia in celiac disease. Mov Disord. 2006;21:427-9.
112. Tison F, Arne P, Henry P. Myoclonus and adult coeliac disease. J Neurol. 1989;236:307-8.
113. Fung VS, Duggins A, Morris JG, Lorentz IT. Progressive myoclonic ataxia associated with celiac disease presenting as unilateral cortical tremor and dystonia. Mov Disord 2000;15:732-4.
114. Bushara KO, Nance M, Gómez CM. Antigliadin antibodies in Huntington's disease. Neurology. 2004;62:132-3.
115. Jacob S, Zarei M, Kenton A, Allroggen H. Gluten sensitivity and neuromyelitis optica: two case reports. J Neurol Neurosurg Psychiatry. 2005;76:1028-30.
116. Keller CE, Gamboa ET, Hays AP, Karlitz J, Lowe G, Green PH, et al. Fatal CNS vasculopathy in a patient with refractory celiac disease and lymph node cavitation. Virchows Arch. 2005;448:1-5.
117. Marie I, Lecomte F, Hachulla E, Antonietti M, Francois A, Levesque H, et al. An uncommon association: celiac disease and dermatomyositis in adults. Clin Exp Rheumatol. 2001;19:201-3.
118. Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, Gibson A, Grunewald RA, Lobo AJ. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry. 1997;63:770-5.
119. Sandyk R, Brennan MJ. Isolated ocular myopathy and celiac disease in childhood. Neurology. 1983;33:792.
120. Kleopa KA, Kyriacou K, Zamba-Papanicolaou E, Kyriakides T. Reversible inflammatory and vacuolar myopathy with vitamin E deficiency in celiac disease. Muscle Nerve. 2005;31:260-5.
121. Williams SF, Mincey BA, Calamia KT. Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura. South Med J. 2003;96:721-3.
122. Iannone F, Lapadula G. Dermatomyositis and celiac disease association: a further case. Clin Exp Rheumatol. 2001;19:757-8.
123. Falcini F, Porfirio B, Lionetti P. Juvenile dermatomyositis and celiac disease. J Rheumatol. 1999;26:1419-20.
124. Kepes JJ, Chou SM, Price LW Jr. Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue. Report of a case with unusual light and electron microscopic features. Neurology. 1975;25:1006-12.
125. Beyenburg S, Scheid B, Deckert-Schluter M, Lagreze HL. Chronic progressive leukoencephalopathy in adult celiac disease. Neurology. 1998;50:820-2.
126. Gobbi C, Buess M, Probst A, Ruegg S, Schraml P, Herrmann R, et al. Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS. Neurology. 2003;60:1718-9.
127. Douglas AP. Celiac disease and lymphoma of intestines and brain. N Engl J Med. 1977;296:821.
128. Collin P, Pirttila T, Nurmikko T, Somer H, Erila T, Keyrilainen O. Celiac disease, brain atrophy, and dementia. Neurology. 1991;41:372-5.
129. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology. 2005;128 4 Suppl 1:92-7.
130. Wills AJ, Unsworth DJ. Gluten ataxia «in perspective». Brain. 2003;126:E4.
131. Volta U, Molinaro N, De Franchis R, Forzenigo L, Landoni M, Fratangelo D, et al. Correlation between IgA antiendomysial antibodies and subtotal villous atrophy in dermatitis herpetiformis. J Clin Gastroenterol. 1992;14:298-301.
132. Combarros O, Infante J, López-Hoyos M, Bartolomé MJ, Berciano J, Corral J, et al. Celiac disease and idiopathic cerebellar ataxia. Neurology. 2000;54:2346.
133. Abele M, Schols L, Schwartz S, Klockgether T. Prevalence of antigliadin antibodies in ataxia patients. Neurology. 2003;60:1674-5.
134. Hadjivassiliou M, Maki M, Sanders DS, Williamson CA, Grunewald RA, Woodroofe NM, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology. 2006;66:373-7.
135. Volta U, De Giorgio R, Granito A, Stanghellini V, Barbara G, Avoni P, et al. Anti-ganglioside antibodies in coeliac disease with neurological disorders. Dig Liver Dis. 2006;38:183-7.
136. Jones RB, Robins GG, Howdle PD. Advances in celiac disease. Curr Opin Gastroenterol. 2006;22:117-23.
137. Picarelli A, Maiuri L, Mazzilli MC, Coletta S, Ferrante P, Di Giovambattista F, et al. Gluten-sensitive disease with mild enteropathy. Gastroenterology. 1996;111:608-16.
138. Horoldt BS, McAlindon ME, Stephenson TJ, Hadjivassiliou M, Sanders DS. Making the diagnosis of coeliac disease: is there a role for push enteroscopy? Eur J Gastroenterol Hepatol. 2004;16:1143-6.
139. Taylor I, Schaffer IE, Berkovic SF. Occipital epilepsies: identification of specific and newly recognized syndromes. Brain. 2003;126:753-69.
140. Wilkinson ID, Hadjivassiliou M, Dickson JM, Wallis L, Grunewald RA, Coley SC, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry. 2005;76:1011-3.
141. Ghezzi A, Filippi M, Falini A, Zaffaroni M. Cerebral involvement in celiac disease: a serial MRI study in a patient with brainstem and cerebellar symptoms. Neurology. 1997;49:1447-50.
142. Beyenburg S, Scheid B, Deckert-Schluter M, Lagreze HL. Chronic progressive leukoencephalopathy in adult celiac disease. Neurology. 1998;50:820-2.
143. Pellecchia MT, Scala R, Perretti A, De Michele G, Santoro L, Filla A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. Neurology. 1999;53:1606-8.
144. Muller AF, Donnelly MT, Smith CM, Grundman MJ, Holmes GK, Toghill PJ. Neurological complications of celiac disease: a rare but continuing problem. Am J Gastroenterol. 1996;91:1430-5.
145. Mauro A, Orsi L, Mortara P, Costa P, Schiffer D. Cerebellar syndrome in adult celiac disease with vitamin E deficiency. Acta Neurol Scand. 1991;84:167-70.
146. Cross AH, Golumbek PT. Neurologic manifestations of celiac disease: proven, or just a gut feeling? Neurology. 2003;60:1566-8.
147. Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol. 2002;169:5595-600.
148. Burk K, Melms A, Schulz JB, Dichgans J. Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Ann Neurol. 2001;50:827-8.
149. Vianello M, Tavolato B, Armani M, Giometto B. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies. Cerebellum. 2003;2:77-9.
150. Gillett HR, Arnott ID, McIntyre M, Campbell S, Dahele A, Priest M, et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology. 2002;122:800-5.
151. Turner SM, Moorghen M, Probert CS. Refractory coeliac disease: remission with infliximab and immunomodulators. Eur J Gastroenterol Hepatol. 2005;17:667-9.
152. Maurino E, Niveloni S, Chernavsky A, Pedreira S, Mazure R, Vázquez H, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol. 2002;97:2595-602.
153. Rolny P, Sigurjonsdottir HA, Remotti H, Nilsson LA, Ascher H, Tlaskalova-Hogenova H, et al. Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol. 1999;94:219-25.
154. Patriarca G, Pogna N, Cammarota G, Schiavino D, Lombardo C, Pollastrini E, et al. An attempt of specific desensitising treatment with gliadin in celiac disease. Int J Immunopathol Pharmacol. 2005;18:709-14.
155. Bye AM, Andermann F, Robitaille Y, Oliver M, Bohane T, Andermann E. Cortical vascular abnormalities in the syndrome of celiac disease, epilepsy, bilateral occipital calcifications, and folate deficiency. Ann Neurol. 1993;34:399-403.
156. Bernasconi A, Bernasconi N, Andermann F, Dubeau F, Guberman A, Gobbi G, et al. Celiac disease, bilateral occipital calcifications and intractable epilepsy: mechanisms of seizure origin. Epilepsia. 1998;39:300-6.
157. Nakken KO, Roste GK, Hauglie-Hanssen E. Coeliac disease, unilateral occipital calcifications, and drug-resistant epilepsy: successful lesionectomy. Acta Neurol Scand. 2005;111:202-4.
158. Carter GT, Weiss MD, Lou JS, Jensen MP, Abresch RT, Martin TK, et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care. 2005;22:55-9.
159. Price CS, Taylor FB. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy. Depress Anxiety. 2005;21:149-53.
160. Rossi M, Maurano F, Luongo D. Immunomodulatory strategies for celiac disease. Int Rev Immunol. 2005;24:479-99.
161. Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:140-7.